Clinical Trials
3
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy
Phase 1
- Conditions
- Age Related Macular Degeneration
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2011-07-27
- Lead Sponsor
- NeoVista
- Target Recruit Count
- 32
- Registration Number
- NCT00809419
- Locations
- 🇺🇸
Retina Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Retinal Institute of Hawaii, Honolulu, Hawaii, United States
🇮🇱Rabin Medical Center, Petach-Tikva, Israel
A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy
Phase 2
Completed
- Conditions
- Wet Age-related Macular Degeneration
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2011-07-27
- Lead Sponsor
- NeoVista
- Target Recruit Count
- 20
- Registration Number
- NCT00679445
- Locations
- 🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
🇺🇸Medical Center Ophthalmology Associates, San Antonio, Texas, United States
A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
Phase 3
- Conditions
- Macular Degeneration
- Interventions
- Device: Epi-Rad90™ Ophthalmic System
- First Posted Date
- 2007-03-30
- Last Posted Date
- 2011-07-27
- Lead Sponsor
- NeoVista
- Target Recruit Count
- 494
- Registration Number
- NCT00454389
- Locations
- 🇺🇸
Retinal Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Retina Center, PC, Tucson, Arizona, United States
🇺🇸Retina-Vitreous Associates Medical, Beverly Hills, California, United States
News
No news found